A systematic review of the efficacy of ketamine for craniofacial pain
A systematic review of the efficacy of ketamine for craniofacial pain
About this item
Full title
Author / Creator
Publisher
United States: Taylor & Francis
Journal title
Language
English
Formats
Publication information
Publisher
United States: Taylor & Francis
Subjects
More information
Scope and Contents
Contents
Craniofacial pain (CFP) poses a burden on patients and health care systems. It is hypothesized that ketamine, an N-methyl-d-aspartate (NMDA) receptor antagonist, can reverse central sensitization associated with causation and propagation of CFP. This systematic review aims to assess the role of ketamine for CFP.
Databases were searched for studi...
Alternative Titles
Full title
A systematic review of the efficacy of ketamine for craniofacial pain
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_37383673
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_37383673
Other Identifiers
ISSN
2474-0527
E-ISSN
2474-0527
DOI
10.1080/24740527.2023.2210167
